Targeting these epigenetic mechanisms with HDAC inhibitors successfully restored normal pulmonary arterial tension in models of pulmonary arterial hypertension (PAH) [9] and PH [10,11]. This evidence concerns the gene HDAC9 and pulmonary arterial hypertension.